SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-17-003162
Filing Date
2017-04-07
Accepted
2017-04-07 17:00:19
Documents
4
Period of Report
2017-04-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tenx_8k.htm 8-K 34368
2 SEPARATION AND GENERAL RELEASE AGREEMENT tenx_ex101.htm EX-10.1 58675
3 PRESS RELEASE tenx_ex991.htm EX-99.1 14382
4 IMAGE logo.jpg GRAPHIC 7802
  Complete submission text file 0001654954-17-003162.txt   119867
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34600 | Film No.: 17750549
SIC: 8731 Services-Commercial Physical & Biological Research